Features May 2018 Issue

New Path for Treating Coronary Artery Disease Discovered

Profound effect of anti-inflammatory drug creates excitement, hope.

Two clinical studies released in 2005 showed that intensive statin therapy also reduced inflammation, as measured by high-sensitivity C-reactive protein (CRP) levels. The study authors felt strongly that the results of these trials could not be explained by LDL-lowering alone, and that the reduction in inflammation was responsible for improved outcomes.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.